on december 17, in order to further promote the transformation and implementation of jinfeng laboratory’s scientific and technological achievements and cultivate new productivity in the field of life and health, it was jointly sponsored by jinfeng laboratory and chongqing science and technology venture capital association, chongqing science and technology financial service center and sichuan provincial equity and the second "investors in jinfeng" and "biomedicine and big health" closed-door special roadshow co-organized by the venture capital association was successfully held at the jinfeng laboratory in the western (chongqing) science city.

more than 30 industry professionals from venture capital institutions, banks, securities, and law firms participated in this event. the event invited dr. yang junjie, founder of proxima venture capital, to give a speech on "opportunities and challenges facing investment in the biomedicine and big health industry" theme sharing, 4 incubated companies of jinfeng laboratory, feinke biotechnology, tianyimei life, huicheng biotechnology, and zhijian life, participated in the road show. the displayed projects covered ai+ biomedicine innovative research and development, nk cell drug research and development, automated cell preparation system, pathological ai-assisted diagnosis and other aspects.

▲visit and interact

the roadshow companies reported on company structure, technical advantages, product planning, team building, development planning, financing needs, etc. investors from 12 venture capital institutions commented on the roadshow projects and expressed their professional opinions, all of which were expressed in jinfeng laboratory with the help of the company, the products developed by the four roadshow companies are all significantly innovative and leading. they are willing to conduct in-depth docking negotiations with the companies after the meeting and initiate due diligence in a timely manner.

during the discussion and exchange session, the participating departments and financial institutions of the high-tech zone had in-depth communication with the roadshow companies, preached on life and health industry policies and financial technology services, actively discussed new business opportunities, and jointly helped projects to quickly achieve marketization and industrialization. .

the "investors in jinfeng" activity aims to build a face-to-face communication platform with investment institutions for the scientific research team of jinfeng laboratory and incubated companies, broaden the financing channels for laboratory scientific and technological innovation projects and incubated companies, and strive to transform more chongqing-identifiable innovative results.

it is worth noting that the "investors into jinfeng" and related investment and financing activities continued to be held at jinfeng laboratory have achieved remarkable results. the roadshow company chongqing zhijian life technology co., ltd. has received the first round of 10 million in 2023 yuan's investment won the first prize of the 13th china innovation and entrepreneurship competition (chongqing division) in 2024, the first prize of the chongqing division of the 2024 "data elements x" competition, and the outstanding enterprise award of the 13th china innovation and entrepreneurship competition. waiting for important awards. chongqing feinke biotechnology co., ltd. has also gained the attention of chongqing municipal government’s seed funds and market-oriented investment institutions through investment activities, and is currently undergoing investment due diligence. in the next step, jinfeng laboratory will continue to organize and carry out such activities, actively build a jinfeng investment and financing service ecosystem, and provide strong support for scientific research project financing and industrialization development.

▲activity site